Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.

POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P.

Lancet. 2008 May 31;371(9627):1839-47. doi: 10.1016/S0140-6736(08)60601-7. Epub 2008 May 12.

2.

Should physicians initiate beta-blocker therapy in patients undergoing non-cardiac surgery? Insights from the POISE trial.

Alonso-Coello P, Paniagua P, Mizera R, Devereaux PJ.

Pol Arch Med Wewn. 2008 Nov;118(11):616-8. Review. No abstract available.

3.

Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial.

Juul AB, Wetterslev J, Gluud C, Kofoed-Enevoldsen A, Jensen G, Callesen T, Nørgaard P, Fruergaard K, Bestle M, Vedelsdal R, Miran A, Jacobsen J, Roed J, Mortensen MB, Jørgensen L, Jørgensen J, Rovsing ML, Petersen PL, Pott F, Haas M, Albret R, Nielsen LL, Johansson G, Stjernholm P, Mølgaard Y, Foss NB, Elkjaer J, Dehlie B, Boysen K, Zaric D, Munksgaard A, Madsen JB, Øberg B, Khanykin B, Blemmer T, Yndgaard S, Perko G, Wang LP, Winkel P, Hilden J, Jensen P, Salas N; DIPOM Trial Group.

BMJ. 2006 Jun 24;332(7556):1482.

4.

Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery.

POISE Trial Investigators, Devereaux PJ, Yang H, Guyatt GH, Leslie K, Villar JC, Monteri VM, Choi P, Giles JW, Yusuf S.

Am Heart J. 2006 Aug;152(2):223-30.

PMID:
16875901
5.

Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.

Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, Xie JX, Liu LS; COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group.

Lancet. 2005 Nov 5;366(9497):1622-32.

PMID:
16271643
6.

CAGS and ACS Evidence Based Reviews in Surgery. 34: effects of ß-blockers in patients undergoing noncardiac surgery.

Mastracci TM, Aarts MA, Cassivi SD, Garcia SA, McLean RF, McFalls EO; Members of the Evidence Based Reviews in Surgery Group.

Can J Surg. 2010 Oct;53(5):342-4.

7.

Beta-blocker therapy in non-cardiac surgery.

Keane M.

Lancet. 2008 Sep 27;372(9644):1145; author reply 1146. doi: 10.1016/S0140-6736(08)61469-5. No abstract available.

PMID:
18926267
8.

[Perioperative beta-blockade for reduction of cardiovascular complications in non-cardiac surgery: advantages and disadvantages].

Koelemay MJ, Legemate DA.

Ned Tijdschr Geneeskd. 2008 Nov 29;152(48):2603-5. Dutch.

PMID:
19102434
9.
10.

Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial.

Brady AR, Gibbs JS, Greenhalgh RM, Powell JT, Sydes MR; POBBLE trial investigators.

J Vasc Surg. 2005 Apr;41(4):602-9.

12.

The experts debate: perioperative beta-blockade for noncardiac surgery--proven safe or not?

Poldermans D, Devereaux PJ.

Cleve Clin J Med. 2009 Nov;76 Suppl 4:S84-92. doi: 10.3949/ccjm.76.s4.14.

13.

The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.

Juul AB, Wetterslev J, Kofoed-Enevoldsen A, Callesen T, Jensen G, Gluud C; Diabetic Postoperative Mortality and Morbidity group.

Am Heart J. 2004 Apr;147(4):677-83.

PMID:
15077084
14.

Beta-blocker management in high-risk patients presenting for non-cardiac surgery: before and after the POISE Trial.

Leslie K, Myles PS, Halliwell R, Paech MJ, Short TG, Walker S.

Anaesth Intensive Care. 2012 Mar;40(2):319-27.

PMID:
22417028
15.

Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers.

Coletta C, Ricci R, Ceci V, Seccareccia F, Rulli F, Mazzuca V, Putini RL, Salustri A, Bottero G, Pasquale M.

G Ital Cardiol. 1999 Feb;29(2):115-24; discussion 125-9.

PMID:
10088066
16.

Beta-blocker therapy in non-cardiac surgery.

Riedel B, Shaw A, Le Manach Y, Aronson S.

Lancet. 2008 Sep 27;372(9644):1146-7. doi: 10.1016/S0140-6736(08)61473-7. No abstract available.

PMID:
18926268
17.

Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis.

Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH.

Lancet. 2008 Dec 6;372(9654):1962-76. doi: 10.1016/S0140-6736(08)61560-3. Epub 2008 Nov 13. Review. Erratum in: Lancet. 2009 May 23;373(9677):1764.

PMID:
19012955
19.

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial.

Tardif JC, McMurray JJ, Klug E, Small R, Schumi J, Choi J, Cooper J, Scott R, Lewis EF, L'Allier PL, Pfeffer MA; Aggressive Reduction of Inflammation Stops Events (ARISE) Trial Investigators.

Lancet. 2008 May 24;371(9626):1761-8. doi: 10.1016/S0140-6736(08)60763-1.

PMID:
18502300
20.

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vítovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Jánosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P.

JAMA. 2000 Mar 8;283(10):1295-302.

PMID:
10714728
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk